Prosecution Insights
Last updated: October 27, 2026

Alyssa Margo Alter Morschauser, USPTO Patent Examiner

Listed by the USPTO as ALTER MORSCHAUSER, ALYSSA MARGO

Tech Center 3700 • Art Units: 3762 3792 3796

This examiner grants 77% of resolved cases

Analysis

ALTER MORSCHAUSER, ALYSSA MARGO examines in tech center 3700 and art unit 3762. The record includes 811 resolved cases, a 76.6% allowance rate, and a 1214-day median time to allowance. Interviews show a 15.7% lift, which is a positive association within a substantial case record. The data gives practitioners a meaningful basis for planning prosecution, while the median timing indicates that a favorable allowance profile does not necessarily imply a short examination period.

The leading companies are Spr Therapeutics Inc., Enlighten Mobility LLC, and Avation Medical Inc. The listed firms are Knobbe, Martens, Olson & Bear, LLP, TAROLLI, SUNDHEIM, COVELL & TUMMINO L.L.P., and BROWN RUDNICK LLP. An interview can be incorporated into response planning, but applicants should continue developing written positions that address the record over an extended timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

76.6%
Allow Rate
+6.6% vs TC avg
863
Total Applications
+15.7%
Interview Lift
1214
Avg Prosecution Days
Based on 811 resolved cases, 2023–2026

Rejection Statute Breakdown

5.0%
§101 Eligibility
26.7%
§102 Novelty
37.1%
§103 Obviousness
17.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18600430 Seamlessly Embedded Heart Rate Monitor Final Rejection Apple Inc.
18682972 METHOD AND SYSTEM FOR MONITORING PATIENTS FOR SEPSIS FOLLOWING DISCHARGE Final Rejection KONINKLIJKE PHILIPS N.V.
18576237 PERSONALIZED THERAPY NEUROSTIMULATION SYSTEMS Final Rejection Cala Health, Inc.
18114662 ELECTRICAL TECHNIQUES FOR BIOMARKER DETECTION IN A COCHLEA Non-Final OA Cochlear Limited
18632577 PEDIATRIC AND ADULT DEFIBRILLATOR Final Rejection ZOLL Medical Corporation
18851480 PATIENT INTERVENTION OF ANTITACHYARRHYTHMIA THERAPY Final Rejection Medtronic, Inc.
18277511 KIT FOR TREATING DAMAGED NERVES Final Rejection Reddress Ltd.
18216258 ADHESIVE LAYER WITH PROTECTIVE BORDER FOR USE IN A TUMOR TREATING FIELDS TRANSDUCER Final Rejection Novocure GmbH
18521093 TRANSVENOUS INTRACARDIAC PACING CATHETER Final Rejection SWIFT SYNC, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Alyssa Margo Alter Morschauser's allowance rate?

76.6% of resolved applications examined by Alyssa Margo Alter Morschauser were allowed (811 resolved cases), compared with 57.3% across Art Unit 3762 over the last five years.

Does an interview help with examiner Alyssa Margo Alter Morschauser?

This examiner's interview lift is +15.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Alyssa Margo Alter Morschauser take to allow a patent?

Applications allowed by Alyssa Margo Alter Morschauser took 1,214 days on average from filing to allowance.

Which art unit does examiner Alyssa Margo Alter Morschauser work in?

Alyssa Margo Alter Morschauser examines applications in Art Unit 3762 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month